Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
18- 10.16After-hours26.10.17 05:18SCHEDULE 13GOwnership#●●●#●●●
ADARx Pharmaceuticals, Inc.
LAV Biosciences Fund V, L.P. and affiliated investment entities have filed a Schedule 13G regarding their ownership of ADARx Pharmaceuticals common stock. The investors, including Yi Shi, executed a joint filing agreement on October 16, 2026, to formalize their collective reporting.…more
$17.53-0.57%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 10.5After-hours26.10.06 06:35SCHEDULE 13DOwnership
ADARx Pharmaceuticals, Inc.
Shareholders of ADARx Pharmaceuticals, Inc., including SR One Capital Management and its affiliated investment entities, have entered into an agreement to file a joint Schedule 13D. This agreement serves as a procedural step to fulfill their collective reporting obligations regarding their ownership of company shares.…more
$17.53-0.57%vs prev closeView filingShare - 10.2After-hours26.10.03 06:36SCHEDULE 13DOwnership
ADARx Pharmaceuticals, Inc.
OrbiMed Advisors LLC and its affiliated entities filed a Schedule 13D on September 28, 2026, regarding their common stock holdings in ADARx Pharmaceuticals, Inc. This filing formalizes a joint filing agreement among the OrbiMed entities to coordinate their reporting obligations.…more
$17.53-0.57%vs prev closeView filingShare
17 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 10.1After-hours26.10.02 05:15Bullish#●●●#●●●#●●●
ADARx Pharmaceuticals Completes Full Exercise of IPO Underwriters' Option…more
ADARx Pharmaceuticals has finalized the full exercise of its underwriters' option to purchase additional shares following its upsized initial public offering. Including a concurrent private placement, the company has raised approximately $602.5 million in total gross proceeds.…more
$17.53-0.57%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
- 9.25Regular26.09.26 01:16
●●●●●●●● ●●●●● ●●●●●●
Adarx Pharmaceuticals successfully completed its IPO by issuing 26.5 million shares at $17 per share. The stock began trading on its first day at $22.10, reflecting a premium over the offering price.…more
$17.53-0.57%vs prev closeShareBenzinga - 9.25Regular26.09.25 23:10
●●●●●●●● ●●●●● ●●●●●●
The trading halt on the newly listed Adarx Pharmaceuticals IPO has been lifted, allowing the security to resume quotation. The stock is now available for regular trading on the market.…more
$17.53-0.57%vs prev closeShareBenzinga
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report